These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 1434999)

  • 1. [Cost-effectiveness study of prevaccination screening tests in vaccination against hepatitis B in hospital health professionals].
    Guillén Grima F; Aguinaga Ontoso I
    Med Clin (Barc); 1992 Sep; 99(9):327-8. PubMed ID: 1434999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cost-effectiveness analysis of different alternatives of universal vaccination against hepatitis B in the region of Murcia].
    Guillén Grima F; Espín Ríos MI
    Med Clin (Barc); 1995 Feb; 104(4):130-6. PubMed ID: 7898156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost effectiveness of hepatitis B vaccination at HIV counseling and testing sites.
    Kim SY; Billah K; Lieu TA; Weinstein MC
    Am J Prev Med; 2006 Jun; 30(6):498-506. PubMed ID: 16704944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost effectiveness of prevaccination screening for hepatitis B antibody.
    Jacobson JJ; La Turno DE; Johnston FK; Shipman C
    J Dent Educ; 1987 Feb; 51(2):94-7. PubMed ID: 3100594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Efficiency of prevaccination screening of anti-HBc in the anti-hepatitis B vaccination programs].
    Navas E; Bayas JM; Taberner JL; Salleras L
    Med Clin (Barc); 1992 Nov; 99(17):641-4. PubMed ID: 1447934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A simplified financial cost-effectiveness analysis of programs for prevention of hepatitis B accidental inoculation among hospital personnel in Thailand.
    Chongsuvivatwong V
    Southeast Asian J Trop Med Public Health; 1989 Jun; 20(2):189-93. PubMed ID: 2532789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Probabilistic cost-effectiveness analysis of the long-term effect of universal hepatitis B vaccination: an experience from Taiwan with high hepatitis B virus infection and Hepatitis B e Antigen positive prevalence.
    Hung HF; Chen TH
    Vaccine; 2009 Nov; 27(48):6770-6. PubMed ID: 19735755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost effectiveness of prevaccination screening of health care workers for immunity to measles, rubella and mumps.
    Ferson MJ; Robertson PW; Whybin LR
    Med J Aust; 1994 Apr; 160(8):478-82. PubMed ID: 8170422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A method for evaluating the hepatitis B vaccination program].
    Corrao G; Calleri M; Carle F; Russo R; Favilli S
    Ann Ist Super Sanita; 1989; 25(2):337-43. PubMed ID: 2531564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effective analysis of hepatitis A prevention in Ireland.
    Rajan E; Shattock AG; Fielding JF
    Am J Gastroenterol; 2000 Jan; 95(1):223-6. PubMed ID: 10638588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cost-benefits of vaccination against hepatitis B in hospital personnel in Venezuela].
    Fernández Barboza R; Rivero D; Echeverría B; Machado IV
    Bol Oficina Sanit Panam; 1991 Jul; 111(1):16-23. PubMed ID: 1834080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An economic evaluation of universal infant vaccination strategies against hepatitis B in Thailand: an analytic decision approach to cost-effectiveness.
    Vimolket T; Poovorawan Y
    Southeast Asian J Trop Med Public Health; 2005 May; 36(3):693-9. PubMed ID: 16124440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-benefit analysis of hepatitis B vaccination.
    Jönsson B
    Postgrad Med J; 1987; 63 Suppl 2():27-32. PubMed ID: 3120169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cost-effectiveness of vaccinating chronic hepatitis C patients against hepatitis A.
    Jacobs RJ; Koff RS; Meyerhoff AS
    Am J Gastroenterol; 2002 Feb; 97(2):427-34. PubMed ID: 11866283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A cost-effectiveness analysis of vaccination against the hepatitis B virus].
    Antoñanzas F; Forcén T; Garuz R
    Med Clin (Barc); 1992 Jun; 99(2):41-6. PubMed ID: 1630178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-benefit analysis of hepatitis a vaccination in Thailand.
    Teppakdee A; Tangwitoon A; Khemasuwan D; Tangdhanakanond K; Suramaethakul N; Sriratanaban J; Poovorawan Y
    Southeast Asian J Trop Med Public Health; 2002 Mar; 33(1):118-27. PubMed ID: 12118439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Analysis on economic efficacy regarding previous strategies and current recommendations for vaccination against hepatitis B virus in China].
    Zhang SX; Dang RB; Zhang WD; Liang XF; Cui FQ
    Zhonghua Liu Xing Bing Xue Za Zhi; 2008 Oct; 29(10):1003-8. PubMed ID: 19173882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness of hepatitis B screening in a mental health institution.
    Leonard J; Holtgrave DR; Johnson RP
    J Fam Pract; 1991 Jan; 32(1):45-8. PubMed ID: 1824638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary high-dose intradermal hepatitis B vaccination in hemodialysis: cost-effectiveness evaluation at 2 years.
    Mat O; Mestrez F; Beauwens R; Muniz-Martinez MC; Dhaene M
    Hemodial Int; 2006 Jan; 10(1):49-55. PubMed ID: 16441827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness of human papillomavirus vaccination in Belgium: do not forget about cervical cancer screening.
    Thiry N; De Laet C; Hulstaert F; Neyt M; Huybrechts M; Cleemput I
    Int J Technol Assess Health Care; 2009 Apr; 25(2):161-70. PubMed ID: 19366497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.